Due to a change in reagent affecting the performance of the Urinary Antigen Detection (UAD) assay, the positivity cut-off values of the assay had to be revised. A number of epidemiological studies have been affected by this change, including the original version of this article \[[@CR1]\].

All samples of the study have been reanalysed and the impact on the study results can be found in the attached Excel sheet (Additional file [1](#MOESM1){ref-type="media"}):Due to change in cut-off for serotype 5 and 14, there is one case of serotype 5 and of serotype 14 less.The revision of the analysis showed 1 additional positive results for serotype 18C and for serotype 23 FOverall the total number of positive UAD results has not changed.

Results of the assay are shown in the corrected Tables [3](#Tab1){ref-type="table"} and [4](#Tab2){ref-type="table"}, included in this erratum.Table 3Cross-table of the results of the BinaxNOW and Urine Antigen Detection assays^a^BinaxNOW assayTotal\
N(%)Negative\
N(%)Positive\
N(%)Urine Antigen Detection AssayNegative N (%)433 (95.0)8 (1.7)441 (96.7)Positive N (%)11 (2.4)4 (0.9)15 (3.3)Total N (%)444 (97.4)12 (2.6)456 (100.0)^a^88 contaminated samples were eliminated from the analysisTable 4Number and proportion of the serotypes in pneumococcal serious lower respiratory tract infections using the Urine Antigen Detection (UAD) assayPneumococcal serotypeN%116.67316.676A213.337 F213.331416.6718C213.3319A533.3323 F16.67Total^a^15100.0^a^15 (3.3 %) out of 456 SLRTI cases were positive for the UAD assay

Additional file {#Sec1}
===============

Additional file 1:**Changes in UAD results.** (XLSX 12 kb)

The online version of the original article can be found under doi:10.1186/s12875-015-0282-1.
